Puig-García, Marta
López-Herraiz, Carmen
Caicedo-Montaño, Cintia
Rivadeneira, María Fernanda
Vásconez-Donoso, Juan
Montalvo-Villacis, Gregorio
Benazizi-Dahbi, Ikram
Parker, Lucy Anne
,
Torres Castillo, Ana Lucía
Peralta, Andrés
Chilet-Rosell, Elisa
Barrera Guarderas, Francisco
Pinto Delgado, Jessica
Hernández, María
Marquez-Figueroa, Mónica
Morales-Garzón, Sergio
Funding for this research was provided by:
European Research Council (804761)
Article History
Received: 22 March 2024
Accepted: 27 September 2024
First Online: 7 October 2024
Declarations
:
: The study protocol was reviewed and approved by the Universidad Miguel Hernández (UMH) project evaluation board (registration number 2018.291.E.OEP), the nationally accredited ethical board at the Pontificia Universidad Católica de Ecuador (PUCE, reference 2019–27-MB), and ethical clearance was provided by the European Research Council Executive Agency (ERCEA, Ref. Ares (2018) 5827042–14/11/2018). Participants were fully informed about the study’s purpose, procedures, potential risks, benefits and the right to withdraw from the study at any time. Written informed consent was required prior to participation in the population survey. Clinical trial number: not applicable.
: Not applicable.
: The authors declare no competing interests.